BioSpace News Archive

Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces the New Zebron™ Gas Management Filters and Click-on Inline Gas Trap, which removes contaminants from carrier gas to reduce gas chromatography system downtime and column damage and deliver pure gas for maximum analytical sensitivity.

The Doctors Company has completed the purchase of Hospitals Insurance Company (HIC), a New York State admitted and licensed insurance company, and FOJP Service Corporation, a New York service organization that provides third-party comprehensive insurance and risk management advisory services to HIC-insured hospitals.

Kessler Institute for Rehabilitation, a Select Medical hospital, has been recognized as the No. 2 rehabilitation hospital in the nation by U.S. News & World Report for 2019-20.

31,611,235 patient records were breached between January and June 2019, according to new data released today in the Protenus Breach Barometer.

Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s PD-L1 IHC 22C3 pharmDx assay for expanded use.

In its third win of the year, NEOFECT has again been honored for its groundbreaking medtech product design. The company’s NeoMano robotic glove has received the internationally acclaimed Red Dot Best of the Best award, the top prize in the Red Dot Design Concept category.

Taro Pharmaceutical Industries Ltd. announced that it plans to release its financial results for the quarter ended June 30, 2019, after the close of market on Thursday August 8, 2019.

Dermira, Inc., a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of people living with chronic skin conditions, will report financial results for the quarter ended June 30, 2019 and provide an operational update after market close on Wednesday, August 7, 2019.

Vertex Pharmaceuticals Incorporated reported consolidated financial results for the second quarter ended June 30, 2019 and increased its full-year 2019 total product revenue guidance.

Hologic, Inc. announced the Company’s financial results for the fiscal third quarter ended June 29, 2019.